Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
6 Patents
#147 in Philadelphia, PA
#1,625 in Pennsylvania
#45,030 in US
Akamara Therapeutics, Inc.
Forward Citations = 1
19 inventors:
Philadelphia, PA, United States of America
Akamara Therapeutics, Inc.
Calculating rank
EPO Patents = 3
Forward Citations = 1
Loading Chart...
Loading Chart...
19 inventors (with patents filed for the assignee):
Shiladitya Sengupta (4 out of 21 patents)
Nimish Gupta (3 out of 3 patents)
Monideepa Roy (3 out of 7 patents)
4. Arindam Sarkar (2 out of 4 patents)
5. Pradip Dutta (2 out of 3 patents)
6. Seikh Samad Hossain (2 out of 3 patents)
7. Heeralal Bassi (1 out of 1 patent)
8. Saurabh Chitre (1 out of 3 patents)
9. Hayley Reece (1 out of 9 patents)
10. Attilia Figini (1 out of 7 patents)
11. Sarkar Arindam (1 out of 1 patent)
12. Gavin Pringle (1 out of 1 patent)
13. Ivan Ruggiero (1 out of 1 patent)
14. Sk Samad Hossain (1 out of 2 patents)
15. Aniruddha Sengupta (1 out of 3 patents)
6 patents:
Company Overview
Akamara Therapeutics is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. With a pipeline of cutting-edge treatments, the company aims to address unmet medical needs and improve patients' quality of life. Through strategic partnerships and a dedicated team of experts, Akamara Therapeutics is committed to advancing breakthrough solutions in the field of neurology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akamara Therapeutics, Inc.. Retrieved from https://idiyas.com/company/akamara-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]